Michel Goldman, MD, PhD, is the founder and co-director of the I³h Institute and Professor of Immunology and Pharmacotherapy at the Université libre de Bruxelles (ULB). He was the Executive Director of the Innovative Medicines Initiative (IMI) from 2009 to 2014. Previously, he served as Head of the Department of Immunology at Erasme Hospital and was the first Director of the Institute for Medical Immunology (ULB).
Michel Goldman’s scientific achievements resulted in an ISI Highly Cited Scientist nomination in 2006 by the Thomson Institute for Scientific Information. In 1992, Michel Goldman received the Medical Prize Lucien Steinberg (shared with Pr. Peter Piot) and in 2000 the Quinquiennal Prize of the Belgian National Fund for Scientific Research for Clinical Sciences. He held the Francqui Chair at the University of Namur in 1999, at the University of Liège in 2003, and the Spinoza chair at the University of Amsterdam, the Netherlands in 2001. In 2007, Michel Goldman was awarded the degree of Doctor Honoris Causa of the University of Lille, France.
Mathias Dewatripont holds a Ph.D. in Economics from Harvard University (1986). Since 1990, he has been Professor of Economics at ULB (part-time between 2011 and 2017, when he served as Executive Director at the National Bank of Belgium, – and, between May 2014 and March 2015, as its Vice-Governor – being responsible for prudential policy and financial stability and a member of the Supervisory Board of the ECB and of the Basel Committee). He is affiliated with ULB’s Solvay Brussels School of Economics and Management (SBS-EM) and ECARES.
Between 1998 and 2011, he was part-time Visiting Professor at MIT and Research Director of CEPR. Laureate of the 1998 Francqui Prize and of the 2003 Yrjo Jahnsson Prize for Economics, he was a founding member of the Scientific Council of the European Research Council (2007-2012). He is a member of the Académie Royale De Belgique and Foreign Honorary Member of the American Academy of Arts and Science. He was also Chairman and then Dean of SBS-EM (2009-2011).
He has widely published in the areas of contract theory, organization economics, innovation, and banking and finance, including Contract Theory (with Patrick Bolton, MIT Press 2005), “Academic Freedom, Private-sector Focus, and the Process of Innovation” (with Philippe Aghion and Jeremy Stein, Rand Journal of Economics, 2008) and “Of Mice and Academics: Examining the Effect of Openness on Innovation” (with Fiona Murray, Philippe Aghion, Julian Kolev and Scott Stern, American Economic Journal: Economic Policy, 2016).
Hilde StevensCo-director and Professor of Health Innovation & Society
Hilde Stevens, PhD, senior researcher and lecturer at the I³h Institute, holds the Interfaculty Chair in Health Innovation & Society, supported by the ULB’s Faculty of Medicine and the Solvay Brussels School of Economics and Management (SBS-EM). She coordinates the Interdisciplinary Program in Healthcare Innovation, organized for Master students, PhD students and postdocs from all (Belgian) universities as well as for professionals. She focuses her research on collaborative innovation models, intellectual property (IP) and mechanisms governing access to medicines in the least developed countries (LDCs). Hilde particularly focuses on the governance and performance of public-private partnerships and their added value in the acceleration of innovative therapy development.
Hilde has been Academic Coordinator, Treasurer and Vice-chair in ENP Belgium (2016-2020), the Belgian Patient Platform, supported by EUPATI (European Patients’ Academy on Therapeutic Innovation). There she laid the foundation for her work on patient-centricity.
She holds a Master Degree in Biomedical Science (Ghent University, Belgium), a Master Degree in General Management (Vlerick Business School, Belgium), Master Degree in Intellectual Property (IP) Law (Brussels University, Belgium) and a PhD in Biomedical Sciences from the University of Leuven (Belgium). Hilde worked as a science consultant (Altran) and was a patent engineer for several years (BiIP).
Micael CastanheiraLead Investigator
Micael Castanheira is Research Director at the Belgian National Science Foundation. He obtained his Ph.D. in Economics from the ULB. He was a post-doctoral fellow at Bocconi University and a visiting fellow at NYU.
His research focuses mainly on political economics and economic policy, one application of the latter being competition in the pharmaceutical market. He also worked on economic reforms (tax, pensions, institution building). Previously, he acted as an economic expert for a multinational enterprise, for the OECD, and for the World Bank. He sits on the scientific board of the National Bank of Belgium and of the Belgian Price Observatory.
Philip VergauwenLead Investigator
Mr. Philip Vergauwen was the Dean of the Solvay Brussels School of Economics and Management (SBS-EM), Université libre de Bruxelles. Previously, he chaired the University Council in Maastricht and was the Dean of Hasselt and Maastricht University. He has a significant international experience in accreditation (Equis and AACSB), was AACSB Board member. He has a clear vision of internationalisation and a solid international network.
Caroline Van SwietenEducational Program - Communication and External Relations Manager
Caroline joined the Institute as Coordinator of the Educational Program. She started her career in Microfinance and Banking in Africa and Belgium. Most recently, she worked as a project and account manager in a communication agency. Then she gained experience in European Affairs and events management as Partnership Manager for the European Business Summit.
Caroline holds a Master’s degree in International Management with a specialization in Economics of Developing Countries from Ichec Brussels Management School. She is currently enrolled in an second Master’s degree in Population and Development Sciences at ULB.
Marie NeunezPh.D. Student
Marie Neunez, Ir, is a PhD student at the Faculty of Medicine thanks to the Belgian Kids’ Fund for Pediatric Research and a Master student in medicine at the Université libre de Bruxelles (ULB). Previously she was a part-time research assistant for 3 years at the Institute for Interdisciplinary Innovation in healthcare (I3h). She was a Clinical Research Coordinator for 2 years in the departments of Nuclear Medicine & Radiotherapy at the Institut Jules Bordet (IJB). She also performed a 5-months internship at BASF SE (Mannheim, Germany) in the Human Health & Nutrition department.
Marie holds a MSc degree in bioengineering with a specialization in Science, Technology and Quality of Food (UCL, Belgium), a Postgraduate degree in Management (ICHEC Business Management School, Belgium) and a certificate in Clinical Studies (Cefochim, Belgium).
Ilaria NataliPh.D. Student
Ilaria Natali is a Ph.D. student at i3health and ECARES (Université Libre de Bruxelles). She holds a bachelor and master’s degree in Economics from the University of Florence and a Research Master’s degree in Economics from the ULB.
Her research interests lie at the intersection of Health Economics and Industrial Organization. Her current research agenda focuses on the socioeconomic and regulatory determinants of opioid analgesic consumption in France and on the role of pharmaceutical advertising. Her latest research project, for instance, studies how the impact of regulatory levers intended to limit opioid use differs across geographical areas depending on their local economic environment. Her future research will assess how pharmaceutical companies’ marketing strategies are modified in response to such regulatory shocks.
Sanae AkodadPh.D. Student
Sanae Akodad holds a Master’s Degree in Biomedical and specialised during her studies in neurosciences.
She is a research fellow at the Institute for Interdisciplinary Innovation in healthcare where she is achieving a Ph.D. in Biomedical Sciences.
She works as an assistant at the Faculty of Medicine of the Université Libre de Bruxelles. Prior to this, she was a science teacher at the College Saint Pierre.
Her research focuses on health economics and cognitive neurosciences in the field of rare diseases.